3-Methoxyphenylpiperazine

3-Methoxyphenylpiperazine (3-MeOPP) is a chemical compound belonging to the class of piperazine derivatives. It is structurally related to other phenylpiperazines, which are known for their psychoactive properties. This compound has been studied for its potential effects on the central nervous system, although it is not widely used in clinical practice.

Chemical Structure and Properties

3-Methoxyphenylpiperazine is characterized by the presence of a methoxy group attached to the phenyl ring of the piperazine structure. Its chemical formula is C11H16N2O, and it has a molecular weight of 192.26 g/mol. The presence of the methoxy group can influence the compound's pharmacological activity and its interaction with various neurotransmitter systems.

Pharmacology

3-Methoxyphenylpiperazine is known to interact with several neurotransmitter receptors in the brain, including serotonin and dopamine receptors. It is believed to act as a partial agonist at certain serotonin receptor subtypes, which may contribute to its psychoactive effects. The compound's exact mechanism of action is not fully understood, and further research is needed to elucidate its pharmacological profile.

Potential Effects

The effects of 3-Methoxyphenylpiperazine on humans are not well-documented, but it is thought to produce mild stimulant and empathogenic effects similar to other phenylpiperazines. Users have reported experiences of increased sociability, mood enhancement, and mild euphoria. However, the safety and efficacy of 3-MeOPP for any therapeutic use have not been established.

Legal Status

The legal status of 3-Methoxyphenylpiperazine varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of approved medical use. It is important for researchers and users to be aware of the legal regulations governing this compound in their respective regions.

Research and Development

Research on 3-Methoxyphenylpiperazine is limited, and most studies have focused on its pharmacological properties and potential effects on the central nervous system. There is ongoing interest in the development of phenylpiperazine derivatives for various therapeutic applications, but 3-MeOPP itself has not been a major focus of clinical research.

Safety and Toxicology

The safety profile of 3-Methoxyphenylpiperazine is not well-established. As with other psychoactive substances, there may be risks associated with its use, including potential for toxicity, adverse reactions, and interactions with other drugs. Caution is advised when handling or experimenting with this compound.

Also see

• Piperazine
• Phenylpiperazine
• Serotonin receptor
• Dopamine receptor

3-Methoxyphenylpiperazine.svg